Kos Statin/Niacin Fixed Dose Combo To Be Supported By NHLBI-Funded Trial
This article was originally published in The Tan Sheet
Executive Summary
The National Heart, Lung & Blood Institute will provide more than $20 mil. in funding for a clinical study comparing a simvastatin/niacin combination therapy to simvastatin alone for prevention of cardiovascular events